Clark Swanson, is co-founder of Vilotos Pharmaceuticals, and was an early advocate and pioneer of drug development in the fight against Covid-19. In 2020, with the Covid-19 pandemic, Mr. Swanson applied the concept of using certain flavonoid based cancer drugs into treatment areas of Covid-19. His commitment to developing therapies for Covid-19 and other diseases has the potential to save countless lives and improve the quality of life for millions of people around the world.

1. Innovative Virology
Research and
Development:
American Entrepreneur
Clark Swanson's
Contributions to
fighting Covid-19

2.  Clark Swanson, is co-founder of Vilotos Pharmaceuticals, and
was an early advocate and pioneer of drug development in the
fight against Covid-19. He maintains an interest in research and
development for drugs also used to treat other infectious
diseases such as HIV/AIDS, Hepatitis, and other viruses. Vilotos
Pharmaceuticals is a virology company based in Baltimore, MD
that focuses on research and development to find cures for
these diseases. Mr. Swanson is a patent author and co-inventor
of the drugs that are being developed.

3.  Mr. Swanson's background in cancer research and drug
development was instrumental in the development of the drug
platform used by Vilotos Pharmaceuticals to create its virology
drug portfolio. Mr. Swanson was an early pioneer in Flavocure
Biotech’s cancer research at Harvard Medical School and having
placed significant financial resources into the search for a cure
to cancer, Swanson facilitated new drug applications and novel
therapies.

4.  In 2020, with the Covid-19 pandemic, Mr. Swanson applied the
concept of using certain flavonoid based cancer drugs into
treatment areas of Covid-19. He recognized the efficacy of
flavonoids, such as Quercetin for SARS (Severe Acute
Respiratory Syndrome) and MERS (Middle East Respiratory
Syndrome). While the drugs performed well against certain
influenza viruses, they did not reach efficacy against SARS-COV-
2 virus.

5.  Mr. Swanson's continues his dedication to finding cures for
diseases and this effort is unwavering. Along with a team of
PhD's and MD's from prestigious universities such as the
University of Maryland, Harvard Medical School, and John's
Hopkins, his drug received Orphan Drug designation from the
FDA. Meanwhile, the Covid-19 pandemic has highlighted the
critical need for new treatments and vaccines to combat
infectious diseases.

6.  Mr. Swanson's dedication to finding cures for diseases has not
gone unnoticed. His work has earned him recognition and
accolades from the medical and scientific communities. His
commitment to developing therapies for Covid-19 and other
diseases has the potential to save countless lives and improve
the quality of life for millions of people around the world.
 More information about Clark Swanson can be found at
www.clarkswanson.com.

7. Thank You
Clark Swanson